Wegovy 1 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DR26F37H4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,416
Award facts
- Contract value 100% obligated
- $18,416.09 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $18,416.09 to AmerisourceBergen Drug Corp for the supply of Wegovy 1 mg/0.5 ml pen injections (0.5 ml units). The contract is a firm fixed-price delivery order with an ultimate completion date of October 30, 2025, and was competitively awarded without set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026.
The underlying IDC enables AmerisourceBergen Drug Corp to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains. AmerisourceBergen Drug Corp's federal procurement history demonstrates consistent capability to fulfill competitive medical supply requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible contract mechanisms. The DLA Troop Support is planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards involving multiple contractors, positioning AmerisourceBergen Drug Corp as a key participant in the federal military healthcare supply chain.
Quick answers
Who was awarded contract SPE2DR26F37H4?
SPE2DR26F37H4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 29, 2025.
How much is contract SPE2DR26F37H4 worth?
The government has obligated $18,416 on SPE2DR26F37H4.
Is contract SPE2DR26F37H4 an order under another contract?
Yes. SPE2DR26F37H4 is a delivery order under SPE2DR25D1051, an indefinite delivery contract.
Was contract SPE2DR26F37H4 competed?
The extent of competition for SPE2DR26F37H4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award